Quarterly Result14 Nov 2026, 07:04 pm
Sandu Pharmaceuticals Declares Unaudited Q2 FY27 Results
AI Summary
Sandu Pharmaceuticals Limited announced the approval of its unaudited financial results for the quarter and half-year ended September 30, 2026. The results were prepared in compliance with Ind-AS and have been reviewed by the statutory auditors, M/s Dave & Dave Chartered Accountants. The Board of Directors approved and took these results on record during their meeting held on November 14, 2026. The detailed financial results and the limited review report are available on the company's website.
Key Highlights
- Board approved unaudited financial results for Q2 FY27.
- Results cover the quarter and half-year ended September 30, 2026.
- Limited Review Report issued by statutory auditors.
- Financials prepared in compliance with Ind-AS.
- Results available on company website and enclosed with filing.
Price Impact
More from SANDUPHQ